For example, EPL120 showed dose-dependent inhibition of the (exogenous) IGF-1 stimulated growth in cell numbers of MCF 7 human breast cancer cells over 72h across the EPL120 dose range 0.04 nM– 4 μM [4]. This evidence concerns the gene IGF1 and breast cancer.